133 related articles for article (PubMed ID: 18977723)
1. Unexpected high rate of wild-type HIV-1 genotype among inmates failing antiretroviral therapy.
Pontali E; Ventura A; Bruzzone B; Icardi G; Ferrari F
HIV Clin Trials; 2008; 9(5):341-7. PubMed ID: 18977723
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.
Pou C; Noguera-Julian M; Pérez-Álvarez S; García F; Delgado R; Dalmau D; Álvarez-Tejado M; Gonzalez D; Sayada C; Chueca N; Pulido F; Ibáñez L; Rodríguez C; Casadellà M; Santos JR; Ruiz L; Clotet B; Paredes R
Clin Infect Dis; 2014 Aug; 59(4):578-88. PubMed ID: 24879788
[TBL] [Abstract][Full Text] [Related]
4. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia.
Ariffin TA; Mohamad S; Yusuf WN; Shueb RH
J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.
Li G; Liang S; Harrison TJ; Tang Z; Shen Z; Wang X; Wu X; Liu W; Liang F; Feng L; Yang J; Fang Z
Intervirology; 2014; 57(5):270-6. PubMed ID: 24994115
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antiretroviral drug resistance in antiretroviral-naive individuals.
James CW; Moffett LE; Szabo S
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):193-5. PubMed ID: 19414829
[TBL] [Abstract][Full Text] [Related]
8. Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.
Sukasem C; Churdboonchart V; Sirisidthi K; Riengrojpitak S; Chasombat S; Watitpun C; Piroj W; Tiensuwan M; Chantratita W
Jpn J Infect Dis; 2007 Sep; 60(5):284-9. PubMed ID: 17881868
[TBL] [Abstract][Full Text] [Related]
9. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon.
Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P
J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266
[TBL] [Abstract][Full Text] [Related]
10. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy.
Filippini P; Liguori G; Scolastico C; Coppola N; Lucariello A; Marrocco C; Catania MR; Ortega De Luna L; Romano Carratelli C; Marinelli P; Sagnelli E; Rossano F
J Chemother; 2004 Dec; 16(6):534-9. PubMed ID: 15700844
[TBL] [Abstract][Full Text] [Related]
12. Viral tropism and antiretroviral drug resistance in HIV-1 subtype C-infected patients failing highly active antiretroviral therapy in Johannesburg, South Africa.
Ketseoglou I; Lukhwareni A; Steegen K; Carmona S; Stevens WS; Papathanasopoulos MA
AIDS Res Hum Retroviruses; 2014 Mar; 30(3):289-93. PubMed ID: 24224886
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
14. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
[TBL] [Abstract][Full Text] [Related]
15. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R;
Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222
[TBL] [Abstract][Full Text] [Related]
16. The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
Di Biagio A; Rusconi S; Marzocchetti A; Signori A; Schiavetti I; Bruzzone B; Monno L; Punzi G; Colao MG; Penco G; Zazzi M; De Luca A;
J Med Virol; 2014 Oct; 86(10):1648-55. PubMed ID: 25042976
[TBL] [Abstract][Full Text] [Related]
17. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
[TBL] [Abstract][Full Text] [Related]
18. Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.
Di Giambenedetto S; Bracciale L; Colafigli M; Cattani P; Pinnetti C; Bacarelli A; Prosperi M; Fadda G; Cauda R; De Luca A
Antivir Ther; 2007; 12(5):835-9. PubMed ID: 17713168
[TBL] [Abstract][Full Text] [Related]
19. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
[TBL] [Abstract][Full Text] [Related]
20. Determinants of virological failure and antiretroviral drug resistance in Mozambique.
Rupérez M; Pou C; Maculuve S; Cedeño S; Luis L; Rodríguez J; Letang E; Moltó J; Macete E; Clotet B; Alonso P; Menéndez C; Naniche D; Paredes R
J Antimicrob Chemother; 2015 Sep; 70(9):2639-47. PubMed ID: 26084302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]